|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 22, 2017 ) Biologics market covers biological products that are derived from genetically modified proteins and human genes. Biologics products include a wide range of recombinant therapeutic proteins, gene therapy tissues, somatic cells, vaccines, and allergenics. These products are isolated from natural sources such as human, animal, and microorganisms by biotechnology methods and other cutting-edge technologies.
For more information about this report at http://www.reportsweb.com/biologics-market-global-report-2017
The global biologics market was estimated to be around $210 billion as of 2016. It made up around 20% of the overall pharmaceuticals market in 2016. The biologics was the second largest market, following the pharmaceutical drugs market in the global pharmaceutical market in 2016.
Treatment of complex diseases
Biologics provide effective treatment for many complex diseases such as Rheumatoid arthritis that have less treatment options. There has been significant advancement for the treatment of Rheumatoid arthritis patients who do not respond to traditional disease-modifying anti-rheumatic drugs. The key biologics used for the treatment of Rheumatoid arthritis include Abatacept (Orencia), Adalimumab (Humira), Anakinra (Kineret), Infliximab (Remicade), and Rituximab (Rituxan).
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001890197/sample
Table of Content
1. Biologics Market Characteristics
2. Biologics Market Size And Growth
3. Pestle Analysis
4. Biologics Market Customer Information
5. Biologics Market Segmentation
6. Biologics Market Regional And Country Analysis
7. Global Biologics Market Comparison With Macro Economic Factors
8. Biologics Market Comparison With Macro Economic Factors Across Countries
9. Biologics Market Comparison With Industry Metrics
10. Asia-Pacific Biologics Market
11. Western Europe Biologics Market
12. Eastern Europe Biologics Market
13. North America Biologics Market
14. South America Biologics Market
15. Middle East Biologics Market
16.1.1. Africa Biologics Market Overview
17. Biologics Market Competitive Landscape
18. Key Mergers And Acquisitions In The Biologics Market
19. Market Background: Pharmaceuticals Market
20. Pharmaceuticals Industry Financial Margins
21. Appendix
Companies Mentioned
Therapeutic Proteins,
Monoclonal Antibodies (MABS),
Vaccines
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001890197/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
